Wealthspire Advisors (New York)’s Diebold Nixdorf Incorporated DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-10,000
Closed -$67K 529
2022
Q1
$67K Hold
10,000
﹤0.01% 424
2021
Q4
$91K Hold
10,000
﹤0.01% 528
2021
Q3
$101K Hold
10,000
﹤0.01% 567
2021
Q2
$128K Sell
10,000
-63
-0.6% -$864 ﹤0.01% 359
2021
Q1
$142K Buy
+10,063
New +$139K ﹤0.01% 687

Other funds holding DBD

Wealthspire Advisors (New York)'s DBD Position: Q2 2022 in Review

Wealthspire Advisors (New York) sold out of Diebold Nixdorf Incorporated (DBD) in Q2 2022, closing a stake of 10,000 shares — an estimated $67K sold.

Wealthspire Advisors (New York) first reported a position in DBD in Q1 2021 and held it in 5 quarters. The position peaked at $142K in Q1 2021. 169 funds tracked by Wall St. Rank hold DBD as of Q2 2022.

  • Wealthspire Advisors (New York) reported no remaining Diebold Nixdorf Incorporated position as of Q2 2022 after selling out during the quarter.
  • Wealthspire Advisors (New York) sold 10,000 Diebold Nixdorf Incorporated shares in Q2 2022, an estimated $67K.
  • Wealthspire Advisors (New York) first reported a position in Diebold Nixdorf Incorporated in Q1 2021 and held it in 5 quarters.
  • Wealthspire Advisors (New York)'s Diebold Nixdorf Incorporated position peaked at $142K in Q1 2021.
  • 169 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q2 2022.

Based on Wealthspire Advisors (New York)'s 13F filing for Q2 2022, filed 9 Aug 2022.